Clin2
NCT07194863Likely a fitNot yet recruiting

Comparing two supplements for fatty liver disease

Essential Phospholipid in Metabolic Associated Fatty Liver Disease

Part of Digestive system, Hormones & metabolism clinical trials.

This trial compares two different supplements—essential phospholipids versus a combination of betaine HCL and L-glutamic acid—to see which one works better for people with fatty liver disease (a condition where fat builds up in the liver). The goal is to find a safe and effective way to improve liver health.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years to 60 years
Study type
Observational

Who can take part

  • You must be older than 18 years old.
  • You must have been diagnosed with fatty liver disease by a doctor (through exams, blood tests, or imaging).
  • You must not be pregnant.
  • You must not have cancer or type 1 diabetes.
  • You must not be currently taking statins or other fatty liver medications.
  • You must not have had weight-loss (bariatric) surgery.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07276204Not yet recruiting· Phase 2
Betaine for fatty liver disease with inflammation

This study tests whether a supplement called betaine can reduce liver fat and damage in people with a type of fatty liver disease that includes inflammation. Half of the participants will receive betaine, and half will receive a placebo (a pill with no active ingredient).

NCT07193927Recruiting· Phase 2
Testing a probiotic mix for fatty liver disease (MASLD)

This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.

Girona, Girona
NCT07285135Not yet recruiting
Glycine supplement for fatty liver disease

This trial studies whether a supplement called glycine (an amino acid) can help improve fatty liver disease. It involves taking the supplement daily and doing MRI scans to see if the fat in your liver changes.

NCT07503431Not yet recruiting
Plant-based diet for fatty liver disease

This trial tests whether eating a plant-based diet can improve liver health and reduce exposure to harmful chemicals in people with fatty liver disease. If you qualify, you may be asked to follow a plant-based diet and have your liver health monitored over time.

Madrid
NCT07085962Not yet recruiting
Studying a natural supplement for liver fat in adults

This study is testing whether a natural supplement called Calculus Bovis Sativus can improve fatty liver disease in people who have fat buildup in their liver but not significant scarring. It aims to see if the supplement is safe and effective for treating this condition.

Wuhan, Hubei
NCT07400367Recruiting
Probiotics and lifestyle changes for fatty liver disease

This trial tests whether taking probiotics plus making lifestyle changes can improve fatty liver and metabolic health. You may qualify if you have liver fat and at least one sign of metabolic problems like high blood sugar or high blood pressure.

New Taipei City

Hear when a new Essential Phospholipid in Metabolic Associated Fatty Liver Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.